U.S. EPA on the Registration Review

Written By Michael Leary

November 2, 2017. Comments to the U.S. EPA on the Registration Review; Draft Human Health and/or Ecological Risk Assessments for Benfluralin, Bromuconazole, Carbaryl, Clodinafop-propargyl, Deltamethrin, Diflufenzopyr, Esfenvalerate, Lufenuron, and Mepiquat Chloride/Mepiquat Pentaborate
Read the comments.

Michael Leary
Previous

European Commission WTO TBT notification G/TBT/N/EU/521 proposal to reclassify propiconazole
Next

U.S. EPA on the Preliminary Ecological Risk Assessment for Registration Review of 2,4 D